ArticleTherapeutic advances in urology2015

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.

Jose E Batista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.